Description

PEG-Based Hydrogel Drug Depot System (Sustained Release Matrix) is a polymer-based delivery platform engineered using polyethylene glycol (PEG) to encapsulate and gradually release therapeutic compounds within a hydrated network. The hydrogel structure acts as a reservoir, enabling controlled diffusion of drugs while maintaining a stable local environment. This approach supports prolonged delivery and reduces the need for repeated administration.

The system allows tuning of release kinetics through adjustment of polymer composition, crosslinking density, and network structure. The PEG backbone provides a reproducible and non-fouling environment, while enabling controlled functionalization if needed. It is compatible with a wide range of therapeutics, including small molecules, proteins, and biologics.

Key features
PEG-based hydrogel system
Sustained and localized drug release
Tunable diffusion and release profiles
Compatible with diverse therapeutics
Reproducible and stable formulation

Typical specifications
Volume 20 mL
Polymer base polyethylene glycol (PEG) hydrogel
Release profile tunable
Encapsulation compatible with small molecules and biologics
Sterility available upon request

Applications
Localized drug delivery
Implantable therapeutic systems
Tissue engineering and regenerative medicine
Cancer therapy research
Controlled release studies